2018 American Transplant Congress
Long-Term Outcomes and Predictors of Survival after Liver Transplantation for Wilson Disease (WD)
Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX.
Background/Aims: Orthotopic liver transplantation (OLT) is life-saving for patients with liver failure from Wilson Disease (WD). Our goal was to evaluate patient and graft survival…2018 American Transplant Congress
One-Year Graft Survival for Longevity Matched Kidneys in the Post-KAS Era
One of the key goals and achievements of KAS was to make better use of available kidneys by improving longevity matching between donor kidneys and…2018 American Transplant Congress
Role of Obesity in Pediatric Liver Transplantation
PURPOSE: Pediatric obesity rates are climbing and the prevalence of obesity in children undergoing liver transplantation now exceeds that of the general population. Studies in…2018 American Transplant Congress
Trends of Racial and Education Disparity in Post-Kidney-Transplant Graft Survival and Patient Survival: Do Different Metrics Lead to Different Conclusions?
Background: Monitoring trends in racial and socioeconomic disparity in disease outcomes is a Healthy People 2020 priority. For some chronic disease outcomes, such as cancer…2018 American Transplant Congress
Delivery of Culturally-Competent Transplant Care among Hmong Kidney Transplant Recipients: Outcomes from a Single Institution
OBJECTIVE: Kidney transplantation (KT) entails delivery of complex, well-coordinated, multidisciplinary care. Cultural and linguistic discordance among transplant providers and patients can lead to healthcare disparities.…2018 American Transplant Congress
Five-Year Outcomes after Randomized Treatment by Rituximab in Early Acute Antibody-Mediated Rejection in Renal Transplantation: Long Term Outcomes of the RITUX ERAH Study
Background The place of rituximab in the treatment of acute antibody-mediated rejection (ABMR) is still controversial. The French multicenter double-blind, placebo-controlled RITUX ERAH study included…2018 American Transplant Congress
Brincidofovir Was Used to Successfully Treat Adenovirus Infections in Solid Organ Transplant Recipients and Other Immunocompromised Patients
Background: Adenovirus (AdV) infections cause significant morbidity and mortality in immunocompromised patients. Brincidofovir (BCV) is an investigational antiviral drug with high in vitro potency against…2018 American Transplant Congress
Waitlist Outcomes and Access to Liver Transplantation for HIV+ Candidates
1JHU, Baltimore; 2SRTR, Minneapolis; 3UAB, Birmingham.
Liver disease is a leading cause of death for HIV+ individuals, and the number of HIV+ liver transplant recipients is increasing. However, since UNOS does…2018 American Transplant Congress
Racial Disparities in Post-Liver Transplant Survival before and after Share 35 Implementation
Background: The Share 35 policy was intended to improve equity in access to liver transplantation by broadening regional sharing of livers for the sickest patients…2018 American Transplant Congress
Two Decades of Eurotransplant Senior Program (ESP): Time on Dialysis Independently Impacts Patient Survival, Allograft Survival and Quality of Life after Kidney Transplantation
In 1999, the Eurotransplant Senior Program (ESP) was implemented and allocates kidneys from deceased-donors ≥65 years to kidney transplant recipients ≥65 years (ESP-KTRs). The ESP…
- « Previous Page
- 1
- …
- 41
- 42
- 43
- 44
- 45
- …
- 66
- Next Page »